Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15
The 1% concentration in this GHK-Cu serum matches the doses used in published human clinical trials, providing researchers with a well-characterized reference concentration
Journal of Clinical Endocrinology & Metabolism, 96 (1), 53-58
Clinical studies demonstrated a 28% reduction in overall mortality over a 12-year period with Epitalon treatment compared to the control group.
Understanding comparative advantages and disadvantages supports informed decision-making
By offering clear communication, a fair return policy, and bundle-based savings, Healthletic reinforces its unwavering commitment to transparency and customer satisfactionkey components when evaluating any wellness product
This article examines the science behind GHK-Cu: its discovery, biological mechanisms, clinical evidence, safety considerations, and the growing body of research exploring its potential role in regenerative medicine
US$ 29.06
US$ 27.32
US$ 23.78
US$ 20.54
